3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cyclophosphamide
415
Cytarabine
337
fludarabine phosphate
231
Rituximab
206
Methotrexate
199
fludarabine
196
venetoclax
174
Azacitidine
174
Busulfan
169
Filgrastim
145
Whole-Body Irradiation
143
Mycophenolic Acid
143
Peripheral Blood Stem Cell Transplantation
141
Tacrolimus
138
Etoposide
130
Vincristine
113
Melphalan
110
Dexamethasone
110
Cyclosporine
102
Granulocyte Colony-Stimulating Factor
100
Imatinib Mesylate
94
Daunorubicin
91
Antilymphocyte Serum
91
Radiotherapy
84
Decitabine
83
Dasatinib
76
Lenalidomide
75
Doxorubicin
71
Prednisone
69
Idarubicin
68
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
AIEOP acute lymphoblastic leukemia protocol
×
Other hematologic neoplasm
×
Clear all
NCT06184009
2025-06-08
HR ALL
Seoul St. Mary's Hospital
Phase 2
Recruiting
370 enrolled